A new era in the treatment of chronic myeloid leukemia

Cancer Control. 2009 Apr;16(2):96-7. doi: 10.1177/107327480901600201.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Bone Marrow Transplantation
  • Drug Resistance, Neoplasm / physiology
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Protein Kinase Inhibitors / therapeutic use

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors